Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2 | 32064677 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2014 | 2014 | |||||||||||
|
2 | 32154594 | 3 prime UTR variant | A/G | snv | 4.4E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
2 | 32086215 | intron variant | C/T | snv | 0.42 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
2 | 32082317 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2014 | 2014 | |||||||||||
|
2 | 32144990 | missense variant | C/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 | |||||||||||||
|
2 | 32116153 | stop gained | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 0 | |||||||||||||
|
2 | 32116153 | stop gained | C/A;T | snv |
|
0.700 | 0 | ||||||||||||||
|
2 | 32116153 | stop gained | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 | |||||||||||||
|
0.807 | 0.280 | 2 | 32116145 | missense variant | T/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.800 | 1.000 | 20 | 1999 | 2014 | ||||||||
|
0.807 | 0.280 | 2 | 32116145 | missense variant | T/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.020 | 1.000 | 2 | 2002 | 2018 | ||||||||
|
0.807 | 0.280 | 2 | 32116145 | missense variant | T/A | snv |
|
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2002 | 2018 | ||||||||
|
0.807 | 0.280 | 2 | 32116145 | missense variant | T/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.807 | 0.280 | 2 | 32116145 | missense variant | T/A | snv |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.807 | 0.280 | 2 | 32116145 | missense variant | T/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.851 | 0.120 | 2 | 32136593 | missense variant | C/G;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.700 | 1.000 | 8 | 2000 | 2012 | ||||||||
|
0.851 | 0.120 | 2 | 32136593 | missense variant | C/G;T | snv |
|
Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.851 | 0.120 | 2 | 32136593 | missense variant | C/G;T | snv |
|
Musculoskeletal Diseases | 0.700 | 0 | |||||||||||
|
0.851 | 0.120 | 2 | 32136593 | missense variant | C/G;T | snv |
|
Musculoskeletal Diseases | 0.700 | 0 | |||||||||||
|
0.851 | 0.120 | 2 | 32136593 | missense variant | C/G;T | snv |
|
0.700 | 0 | ||||||||||||
|
0.851 | 0.120 | 2 | 32136593 | missense variant | C/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.882 | 0.080 | 2 | 32141906 | missense variant | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.800 | 1.000 | 25 | 1999 | 2016 | ||||||||
|
0.882 | 0.080 | 2 | 32141906 | missense variant | G/A | snv |
|
Nervous System Diseases | 0.700 | 1.000 | 21 | 1999 | 2016 | ||||||||
|
0.882 | 0.280 | 2 | 32063962 | stop gained | C/A;T | snv | 4.1E-06; 4.6E-03 |
|
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2004 | 2008 | |||||||
|
0.882 | 0.280 | 2 | 32063962 | stop gained | C/A;T | snv | 4.1E-06; 4.6E-03 |
|
Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.280 | 2 | 32063962 | stop gained | C/A;T | snv | 4.1E-06; 4.6E-03 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 |